2 completed, 1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Generalized Pustular Psoriasis (GPP): new trials by email Literature Review of Generalized Pustular Psoriasis (GPP) trials Research Report on Generalized Pustular Psoriasis (GPP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Generalized Pustular Psoriasis Registry in Costa Rica Generalized Pustular Psoriasis, Generalized Pustular Psoriasis (GPP) | Not yet recruiting | Caja Costarricense de Seguro Social | 50 | 2026-05-01 | 2026-03-09 | |
| Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists AI-based medical device for aided diagnosis in Dermatology - Pustular Psoriasis (PP), Generalized Pustular Psoriasis (GPP) | Completed | AI Labs Group S.L | 15 | 2024-06-01 | 2026-02-24 | |
| Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) HB0034, Placebo - Generalized Pustular Psoriasis (GPP) | Phase 2 | Recruiting | Shanghai Huaota Biopharmaceutical Co., Ltd. | 33 | 2024-02-29 | 2025-03-19 |
| Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP) Adalimumab - Generalized Pustular Psoriasis (GPP), Adalimumab | Phase 3 | Completed | AbbVie | 10 | 2015-09-28 | 2019-01-14 |
Psoriasis (4) · Acne Conglobata (1) · Acne Vulgaris (1) · Acute Generalized Exanthematous Pustulosis (1) · Dermatitis, Seborrheic (1) · Hidradenitis Suppurativa (1) · Impetigo (1) · Keratosis, Seborrheic (1) · Pemphigus (1) · Rare Diseases (1) · Skin Diseases (1) · Tinea (1)
Skin Diseases, Papulosquamous (4) · Skin and Connective Tissue Diseases (4) · Skin Diseases (3) · Acneiform Eruptions (1) · Autoimmune Diseases (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Chemically-Induced Disorders (1) · Dermatitis (1) · Dermatomycoses (1) · Disease Attributes (1) · Drug Eruptions (1) · Drug Hypersensitivity (1) · Drug-Related Side Effects and Adverse Reactions (1) · Gram-Positive Bacterial Infections (1)
Adalimumab (1)
AI Labs Group S.L (1) · AbbVie (1) · Caja Costarricense de Seguro Social (1) · Shanghai Huaota Biopharmaceutical Co., Ltd. (1)
China (1) · Costa Rica (1) · Spain (1)
Anne Robinson, PharmD (1) · Antonio Martorell, PhD (1)